An increase in PrPC expression has been associated with a poor prognosis and reported in a variety of human cancers, including pancreatic cancer, breast cancer, gastric carcinoma, osteosarcoma, and melanoma [18,19,20,21,22]. This evidence concerns the gene PRNP and familial pancreatic carcinoma.